Blue Whale Capital LLP Makes New Investment in Danaher Corporation $DHR

Key Points

• Blue Whale Capital LLP acquired 91,913 Danaher shares worth approximately $17.5 million in the second quarter, making DHR about 0.6% of its portfolio and its 26th-largest holding.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $228.91. Ratings include one Strong Buy, 19 Buys, and five Holds.
• Danaher’s latest quarterly results exceeded expectations, with earnings of $1.94 per share versus the $1.85 consensus and revenue of $6.26 billion, up 5.5% year over year.

Blue Whale Capital LLP bought a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 91,913 shares of the conglomerate's stock, valued at approximately $17,508,000. Danaher comprises approximately 0.6% of Blue Whale Capital LLP's portfolio, making the stock its 26th largest holding.

A number of other large investors also recently made changes to their positions in DHR. Main Street Group LTD acquired a new stake in shares of Danaher during the first quarter worth $25,000. N.E.W. Advisory Services LLC bought a new stake in Danaher in the second quarter valued at about $25,000. JPL Wealth Management LLC acquired a new position in Danaher in the third quarter valued at about $25,000. WFA of San Diego LLC bought a new position in Danaher during the second quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC bought a new position in Danaher during the fourth quarter worth about $27,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on DHR. Evercore reaffirmed an "outperform" rating and issued a $230.00 price target on shares of Danaher in a research note on Monday, July 6th. Royal Bank Of Canada lifted their price objective on shares of Danaher from $200.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 22nd. Wolfe Research downgraded shares of Danaher from an "outperform" rating to a "peer perform" rating in a research note on Monday, June 1st. DZ Bank started coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a "buy" rating and a $210.00 target price on the stock. Finally, HSBC reduced their price target on shares of Danaher from $270.00 to $230.00 and set a "buy" rating on the stock in a research report on Wednesday, June 3rd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $228.91.

Danaher Trading Up 0.3%

NYSE DHR opened at $219.42 on Monday. The firm has a market cap of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The stock's 50-day moving average is $195.80 and its 200-day moving average is $192.40. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion for the quarter, compared to analysts' expectations of $6.12 billion. During the same quarter in the previous year, the business posted $0.77 EPS. Danaher's revenue for the quarter was up 5.5% on a year-over-year basis. Sell-side analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source